Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 24 results.
User Information
Export Records
  1. 1.   The Myeloid-Specific Transcription Factor PU.1 Upregulates Mannose Receptor Expression but Represses Basal Activity of the HIV-LTR Promoter
  2. Kao, Sandra; Miyagi, Eri; Mallorson, Rosa; Saito, Hideki; Sukegawa, Sayaka; Mukherji, Abhik; Mateja,Allyson; Ferhadian, Damien; Fabryova, Helena; Clouse, Kathleen; Strebel, Klaus
  3. Journal of Virology. 2022, Jun 29; e0065222.
  1. 2.   Leucine zipper transcription factor-like 1 binds adaptor protein complex-1 and 2 and participates in trafficking of transferrin receptor 1
  2. Promchan,Kanyarat; Natarajan,Ven
  3. PloS one. 2020, JAN 2; 15(1): e0226298.
  1. 3.   Leishmania-Derived Trimannose Modulates the Inflammatory Response To Significantly Reduce Leishmania major-Induced Lesions
  2. Grinnage-Pulley, Tara; Kabotso, Daniel E. K.; Rintelmann, Chelsea L.; Roychoudhury, Rajarshi; Schaut, Robert G.; Toepp, Angela J.; Gibson-Corley, Katherine N.; Parrish, Molly; Pohl, Nicola L. B.; Petersen, Christine A.
  3. Infection and Immunity. 2018, Jan; 86: e00672-17.
  1. 4.   The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells
  2. Alexandre, K. B.; Gray, E. S.; Mufhandu, H.; McMahon, J. B.; Chakauya, E.; O'Keefe, B. R.; Chikwamba, R.; Morris, L.
  3. Virology. 2012, Feb; 423(2): 175-186.
  1. 5.   Monomerization of Viral Entry Inhibitor Griffithsin Elucidates the Relationship between Multivalent Binding to Carbohydrates and anti-HIV Activity
  2. Moulaei, T.; Shenoy, S. R.; Giomarelli, B.; Thomas, C.; McMahon, J. B.; Dauter, Z.; O'Keefe, B. R.; Wlodawer, A.
  3. Structure. 2010, Sep; 18(9): 1104-1115.
  1. 6.   Hydrolytic reactivity trends among potential prodrugs of the O-2-glycosylated diazeniumdiolate family. Targeting nitric oxide to macrophages for antileishmanial activity
  2. Valdez, C. A.; Saavedra, J. E.; Showalter, B. M.; Davies, K. M.; Wilde, T. C.; Citro, M. L.; Barchi, J. J.; Deschamps, J. R.; Parrish, D.; El-Gayar, S.; Schleicher, U.; Bogdan, C.; Keefer, L. K.
  3. Journal of Medicinal Chemistry. 2008 51(13): 3961-3970.
  1. 7.   Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1
  2. Sabado, R. L.; Babcock, E.; Kavanagh, D. G.; Tjomsl, V.; Walker, B. D.; Lifson, J. D.; Bhardwaj, N.; Larsson, M.
  3. European Journal of Immunology. 2007, Jul; 37(7): 1752-1763.
  1. 8.   The novel fold of scytovirin reveals a new twist for antiviral entry inhibitors
  2. McFeeters, R. L.; Xiong, C. Y.; O'Keefe, B. R.; Bokesch, H. R.; McMahon, J. B.; Ratner, D. M.; Castelli, R.; Seeberger, P. H.; Byrd, R. A.
  3. Journal of Molecular Biology. 2007, Jun; 369(2): 451-461.
  1. 9.   Oligosaccharide preferences of beta 1,4-galactosyltransferase-I: Crystal structures of Met340His mutant of human beta 1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety
  2. Ramasamy, V.; Ramakrishnan, B.; Boeggeman, E.; Ratner, D. M.; Seeberger, P. H.; Qasba, P. K.
  3. Journal of Molecular Biology. 2005, OCT 14; 353(1): 53-67.
  1. 10.   Proteins that bind high-mannose sugars of the HIV envelope
  2. Botos, I.; Wlodawer, A.
  3. Progress in Biophysics and Molecular Biology. 2005, JUN; 88(2): 233-282.
  1. 11.   Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp
  2. Mori, T.; O'Keefe, B. R.; Sowder, R. C.; Bringans, S.; Gardella, R.; Berg, S.; Cochran, P.; Turpin, J. A.; Buckheit, R. W.; McMahon, J. B.; Boyd, M. R.
  3. Journal of Biological Chemistry. 2005, MAR 11; 280(10): 9345-9353.
  1. 12.   Replacing acid alpha-glucosidase in Pompe disease: Recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers
  2. Raben, N.; Fukuda, T.; Gilbert, A. L.; de Jong, D.; Thurberg, B. L.; Mattaliano, R. J.; Meikle, P.; Hopwood, J. J.; Nagashima, K.; Nagaraju, K.; Plotz, P. H.
  3. Molecular Therapy. 2005, JAN; 11(1): 48-56.
  1. 13.   Intraspecific mating with CzechII/Ei mice rescue lethality associated with loss of function mutations of the imprinted genes, Igf2r and Cdkn1c
  2. Hagan, J. P.; Kozlov, S. V.; Chiang, Y. S.; Sewell, L.; Stewart, C. L.
  3. Genomics. 2004, NOV; 84(5): 836-843.
  1. 14.   Mycoplasma testudineum sp nov., from a desert tortoise (Gopherus agassizii) with upper respiratory tract disease
  2. Brown, D. R.; Merritt, J. L.; Jacobson, E. R.; Klein, P. A.; Tully, J. G.; Brown, M. B.
  3. International Journal of Systematic and Evolutionary Microbiology. 2004, SEP; 54(Part 5): 1527-1529.
  1. 15.   Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells
  2. Megjugorac, N. J.; Young, H. A.; Amrute, S. B.; Olshalsky, S. L.; Fitzgerald-Bocarsly, P.
  3. Journal of Leukocyte Biology. 2004 75(3): 504-514.
  1. 16.   Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells
  2. Turville, S. G.; Santos, J. J.; Frank, I.; Cameron, P. U.; Wilkinson, J.; Miranda-Saksena, M.; Dable, J.; Stossel, H.; Romani, N.; Piatak, M.; Lifson, J. D.; Pope, M.; Cunningham, A. L.
  3. Blood. 2004 103(6): 2170-2179.
  1. 17.   Identification and characterization of peptides that bind to cyanovirin-N, a potent human immunodeficiency virus-inactivating protein
  2. Han, Z. Z.; Simpson, J. T.; Fivash, M. J.; Fisher, R.; Mori, T.
  3. Peptides. 2004 25(4): 551-561.
  1. 18.   Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin
  2. O'Keefe, B. R.; Smee, D. F.; Turpin, J. A.; Saucedo, C. J.; Gustafson, K. R.; Mori, T.; Blakeslee, D.; Buckheit, R.; Boyd, M. R.
  3. Antimicrobial Agents and Chemotherapy. 2003 47(8): 2518-2525.
  1. 19.   Molecular cloning of mouse collectin liver 1
  2. Kawai, T.; Suzuki, Y.; Eda, S.; Kase, T.; Ohtani, K.; Sakai, Y.; Keshi, H.; Fukuoh, A.; Sakamoto, T.; Nozaki, M.; Copeland, N. G.; Jenkins, N. A.; Wakamiya, N.
  3. Bioscience Biotechnology and Biochemistry. 2002 66(10): 2134-2145.
  1. 20.   Multisite and multivalent binding between cyanovirin-N and branched oligomannosides: Calorimetric and NMR characterization
  2. Shenoy, S. R.; Barrientos, L. G.; Ratner, D. M.; O'Keefe, B. R.; Seeberger, P. H.; Gronenborn, A. M.; Boyd, M. R.
  3. Chemistry & Biology. 2002 9(10): 1109-1118.
  1. 21.   Isolation and characterization of Myrianthus holstii lectin, a potent HIV-1 inhibitory protein from the plant Myrianthus holstii
  2. Charan, R. D.; Munro, M. H. G.; O'Keefe, B. R.; Sowder, R. C.; McKee, T. C.; Currens, M. J.; Pannell, L. K.; Boyd, M. R.
  3. Journal of Natural Products. 2000 63(8): 1170-1174.
  1. 22.   Involvement of sugars in protein-protein interactions
  2. Qasba, P. K.
  3. Carbohydrate Polymers. 2000 41(3): 293-309.
  1. 23.   Chronic viral hepatitis and the human genome
  2. Thio, C. L.; Thomas, D. L.; Carrington, M.
  3. Hepatology. 2000 31(4): 819-827.
  1. 24.   A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages
  2. Masumoto, M.; Tanaka, T.; Kaisho, T.; Sanjo, H.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Akira, S.
  3. Journal of Immunology. 1999 163(9): 5039-5048.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel